Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRKR

Marker Therapeutics Inc

May 14 • 04:00PM ET

1.46

+0.03 2.10 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: INAB CNTX XLO PGEN IMNN

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.91	Insider Own	19.03%	Shs Outstand	16.67M	Perf Week	1.39%
Market Cap	24.34M	Forward P/E	-	EPS next Y	-1.02	Insider Trans	0.00%	Shs Float	13.50M	Perf Month	-7.59%
Enterprise Value	7.30M	PEG	-	EPS next Q	-0.18	Inst Own	12.92%	Short Float	1.12%	Perf Quarter	1.39%
Income	-12.16M	P/S	6.86	EPS this Y	-25.87%	Inst Trans	4.45%	Short Ratio	1.26	Perf Half Y	56.70%
Sales	3.55M	P/B	1.45	EPS next Y	-2.19%	ROA	-59.20%	Short Interest	0.15M	Perf YTD	-2.01%
Book/sh	1.01	P/C	1.43	EPS next 5Y	-	ROE	-68.81%	52W High	4.07 -64.13%	Perf Year	30.36%
Cash/sh	1.02	P/FCF	-	EPS past 3/5Y	39.48% 33.49%	ROIC	-72.42%	52W Low	0.81 80.27%	Perf 3Y	16.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.31% 50.02%	Gross Margin	-	Volatility	4.30% 5.72%	Perf 5Y	-93.48%
Dividend TTM	-	EV/Sales	2.06	EPS Y/Y TTM	23.89%	Oper. Margin	-350.68%	ATR (14)	0.09	Perf 10Y	-97.85%
Dividend Ex-Date	-	Quick Ratio	8.39	Sales Y/Y TTM	-46.19%	Profit Margin	-342.96%	RSI (14)	48.56	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.39	EPS Q/Q	75.76%	SMA20	-1.78%	Beta	1.43	Target Price	7.87
Payout	-	Debt/Eq	0.00	Sales Q/Q	-51.00%	SMA50	1.09%	Rel Volume	0.43	Prev Close	1.43
Employees	5	LT Debt/Eq	0.00	Earnings	Mar 18 AMC	SMA200	11.18%	Avg Volume	119.73K	Price	1.46
IPO	Jan 05, 1998	Option/Short	No / Yes	EPS/Sales Surpr.	48.95% 61.43%	Trades		Volume	51,710	Change	2.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)